DDX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.595200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.662400E-01
Normal-vs-Stage2
7.757800E-01
Normal-vs-Stage3
5.502400E-01
Normal-vs-Stage4
1.484620E-01
Stage1-vs-Stage2
9.841600E-01
Stage1-vs-Stage3
3.418200E-01
Stage1-vs-Stage4
1.980040E-01
Stage2-vs-Stage3
2.737800E-01
Stage2-vs-Stage4
1.448580E-01
Stage3-vs-Stage4
6.477900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.344600E-01
Normal-vs-AfricanAmerican
6.158800E-01
Normal-vs-Asian
6.913600E-01
Caucasian-vs-AfricanAmerican
8.614400E-01
Caucasian-vs-Asian
1.960550E-01
AfricanAmerican-vs-Asian
2.555600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.901600E-01
Normal-vs-Female
7.211600E-01
Male-vs-Female
7.491000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.102000E-01
Normal-vs-Age(41-60Yrs)
4.995400E-01
Normal-vs-Age(61-80Yrs)
8.955600E-01
Normal-vs-Age(81-100Yrs)
4.595000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.048400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.914000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.093400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.092160E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.311200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.535600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.935200E-01
Normal-vs-Daily Drinker
8.841600E-01
Normal-vs-Weekly Drinker
9.347600E-01
Normal-vs-Occasional Drinker
3.193800E-01
Normal-vs-Social Drinker
5.106000E-01
Non Drinker-vs-Daily Drinker
7.213200E-01
Non Drinker-vs-Weekly Drinker
8.735400E-01
Non Drinker-vs-Occasional Drinker
3.209700E-02
Non Drinker-vs-Social Drinker
1.650220E-01
Daily Drinker-vs-Weekly Drinker
6.885800E-01
Daily Drinker-vs-Occasional Drinker
3.677600E-02
Daily Drinker-vs-Social Drinker
1.511400E-01
Weekly Drinker-vs-Occasional Drinker
1.319200E-01
Weekly Drinker-vs-Social Drinker
3.485600E-01
Occasional Drinker-vs-Social Drinker
5.885200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.745380E-01
Normal-vs-Grade 2
1.382410E-02
Normal-vs-Grade 3
1.301840E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.901800E-01
Grade 1-vs-Grade 3
3.972500E-02
Grade 1-vs-Grade 4
1.745380E-01
Grade 2-vs-Grade 3
9.811700E-02
Grade 2-vs-Grade 4
1.382410E-02
Grade 3-vs-Grade 4
1.301840E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.870000E-01
Normal-vs-NonDiabetic
8.405600E-01
Diabetic-vs-NonDiabetic
9.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.764800E-01
Normal-vs-NoPancreatitis
8.154000E-01
Pancreatitis-vs-NoPancreatitis
6.883000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.947800E-01
Normal-vs-N1
7.604600E-01
N0-vs-N1
5.617000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.976000E-01
Normal-vs-TP53-NonMutant
7.552600E-01
TP53-Mutant-vs-TP53-NonMutant
1.665750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
